Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection a randomized, double-blind, placebo-controlled trial

Richard T. D'Aquila*, Michael D. Hughes, Victoria A. Johnson, Margaret A. Fischl, Jean Pierre Sommadossi, Song Heng Liou, Joseph Timpone, Maureen Myers, Nesli Basgoz, Manette Niu, Martin S. Hirsch, Michael Saag, Jill Weingarten, John Gnann, Diane Havlir, Chris Fegan, Stephen Spector, Douglas Richman, Mark Jacobson, Kathy DybeckPatrick Joseph, Kathleen Clanon, Stacey McKenzie, Pam Daniel, Dale Dayton, Jill Leonard, Robert Schooley, Daniel Kuritzkes, Graham Ray, Beverly Putnam, Dushyantha Jayaweera, Janie Patrone-Reese, Thomas Tanner, Jo Moebus, Nancy Reed, Renee St Jacque, Keith Henry, Susan Swindells, Joe Eron, David Ragan, James Horton, Timothy Lane, Ian Frank, Anne Norris, Roger Pomerantz, Stephen Hauptman, Jan Geiseler, John Leedom, Frances Canchola, Connie Olson, Lawrence Deyton, Carla Pettinelli

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

268 Scopus citations

Fingerprint Dive into the research topics of 'Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection a randomized, double-blind, placebo-controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences